Ultragenyx To Participate At Investor Conferences In London
UBS Global Biopharma Conference 2026
- Monday, November 16, 2026, Emil Kakkis, M.D., Ph.D., President and Chief Executive Officer, Eric Crombez, M.D., Chief Medical Officer, and Howard Horn, Chief Financial Officer, will participate in a fireside chat and host 1x1 meetings.
2026 Jefferies Global Healthcare Conference
- Tuesday, November 17, 2026, Emil Kakkis, Eric Crombez, and Howard Horn will participate in a fireside chat and host 1x1 meetings.
The live and archived webcast of the fireside chat will be accessible from the company's website at .
About Ultragenyx
Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultra-rare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease.
For more information on Ultragenyx, please visit the company's website at: .
Contacts – Ultragenyx
Investors
Joshua Higa
...
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment